Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Ascension posts a major financial comeback, cutting operating losses from $491M to $120M in FY2026. The nonprofit health system credited a tighter acute care footprint, outpatient expansion, and its $3.9B AmSurg acquisition for the turnaround. Net income hit $1.5 billion, fueled in large part by nearly $2.1 billion in investment returns.
Ascension wrapped its 2026 fiscal year on a high note, reporting a $119.8 million operating loss — a dramatic improvement from the $490.9 million loss the year prior. The nonprofit health system, one of the largest in the country, credited a multi-year strategy of tightening its acute care footprint while aggressively expanding outpatient services, including its landmark $3.9 billion acquisition of AmSurg, which added 312 ambulatory surgery centers to its network.
On a same-facility basis, total operating revenue grew 9.8% and net income rose $826 million year over year. Nearly $2.1 billion in net investment returns helped push the bottom line to a $1.5 billion net income. Volumes broadly increased across the system, and Ascension also reported roughly $2.6 billion in community benefits, including $1.5 billion in uncompensated care for Medicare patients.
By the Numbers:
Why it matters: Ascension's turnaround signals that large nonprofit health systems can meaningfully reverse financial distress through strategic restructuring — shifting care to lower-cost outpatient settings and pursuing targeted acquisitions. As health systems nationwide grapple with rising costs and thin margins, Ascension's playbook offers a closely watched model for sustainable recovery.
